1,3-dipropyl-8-cyclopentylxanthine has been researched along with B16 Melanoma in 2 studies
DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Woodhouse, EC | 1 |
| Amanatullah, DF | 1 |
| Schetz, JA | 1 |
| Liotta, LA | 1 |
| Stracke, ML | 1 |
| Clair, T | 1 |
| Merighi, S | 1 |
| Varani, K | 1 |
| Gessi, S | 1 |
| Cattabriga, E | 1 |
| Iannotta, V | 1 |
| Ulouglu, C | 1 |
| Leung, E | 1 |
| Borea, PA | 1 |
2 other studies available for 1,3-dipropyl-8-cyclopentylxanthine and B16 Melanoma
| Article | Year |
|---|---|
Adenosine receptor mediates motility in human melanoma cells.
Topics: Adenosine; Adenosine Monophosphate; Animals; Chemotaxis; CHO Cells; Cricetinae; Dose-Response Relati | 1998 |
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line.
Topics: Adenosine Deaminase; Binding, Competitive; Calcium; Cell Membrane; Cyclic AMP; Humans; Melanoma, Exp | 2001 |